🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Konstanze Döhner

University Hospital Ulm

ORCID: 0000-0002-2261-9862

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group”.

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group

Leukemia(2016)10.1038/leu.2016.185

N/A

2.6DataRank · unranked

40 citations

A Corbacioglu, V I Gaidzik, P Paschka, D Weber, M Heuser +42 more

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Leukemia(2021)10.1038/s41375-021-01323-0

N/A

2.1DataRank · unranked

90 citations

Ling Du, Tamara J. Luck, Axel Benner, Julia Krzykalla, Insa Gathmann +25 more

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

Blood Advances(2020)10.1182/bloodadvances.2020002904

N/A

1.5DataRank · unranked

61 citations

Richard A. Larson, Dan Jones, Guido Marcucci, Thomas W. Prior, Jürgen Krauter +32 more

Germline variants drive myelodysplastic syndrome in young adults

Leukemia(2021)10.1038/s41375-021-01137-0

N/A

0DataRank · unranked

66 citations

Jane E. Churpek, Tom Walsh, Sioḃán Keel, Marja Hakkarainen, Thomas Schroeder +30 more

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

Leukemia(2022)10.1038/s41375-022-01650-w

N/A

0DataRank · unranked

39 citations

Maral Saadati, Lars Bullinger, Richard A. Larson, Tiziana Ottone, Sergio Amadori +18 more

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel

American Journal of Hematology(2023)10.1002/ajh.27087

N/A

0DataRank · unranked

24 citations

Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman +12 more

Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

Blood(2024)10.1182/blood.2024025802

N/A

0DataRank · unranked

25 citations

Giovanni Barosi, Francesco Passamonti, Juan Carlos Hernández‐Boluda, Prithviraj Bose, Konstanze Döhner +33 more

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

Leukemia(2024)10.1038/s41375-024-02143-8

N/A

0DataRank · unranked

6 citations

Andrew H. Wei, Sumithra J. Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse‐Chieh Teh +24 more

Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia

Science(2020)10.1126/science.aax5863

N/A

0DataRank · unranked

275 citations

Stephanie M. Kim, Eric Wong, Charlie Hatton, Hugh Giovinazzo, Jayant Y. Gadrey +9 more

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Blood(2021)10.1182/blood.2021013626

N/A

0DataRank · unranked

738 citations

Sylvie Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai +40 more